Preventing repeat blood clots from IV catheters in cancer patients
Part of Cancer, Heart & circulation, Infections clinical trials.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have active cancer (diagnosed or treated in the last 6 months, or cancer that has spread or is not in remission)
- You have had a confirmed blood clot in an arm or chest catheter that was treated with blood thinners for at least 3 months
- You are not currently bleeding or have conditions that make blood thinners unsafe
- You are not pregnant or breastfeeding (if taking a certain blood thinner)
- You have a life expectancy of more than 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
This trial tests whether a daily pill called edoxaban can prevent blood clots that sometimes form around a central venous catheter in people with cancer. If it works, it could lower the risk of a dangerous clot without major side effects.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.